查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1994748

2026年全球基因治疗释放检测市场报告

Release Testing For Gene Therapy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基因治疗上市试验市场发展迅速。预计该市场规模将从2025年的14.3亿美元成长到2026年的16.7亿美元，复合年增长率（CAGR）为16.3%。过去几年成长要素包括基因治疗临床试验数量的增加、监管品质标准的严格提高、病毒载体生产的扩大、生技药品检测实验室数量的增加以及先进医疗技术核准数量的上升。

预计未来几年基因治疗产品放行检测市场将快速成长，到2030年将达到30.8亿美元，复合年增长率（CAGR）为16.5%。预测期内的成长预计将受到以下因素的推动：商业基因治疗的扩张、对快速发货前检测需求的增加、合约检测服务的扩展、监管力度的加强以及自动化品管平台的应用。预测期内的关键趋势包括：高灵敏度疗效检测、快速无菌检测平台、自动化大量出货分析、多参数品管以及先进的载体鑑定检测。

全球基因疗法核准数量的不断增长预计将推动基因疗法上市试验市场的发展。基因疗法是一种医疗实践，涉及在患者细胞内引入、移除或修改遗传物质，以治疗或预防疾病。全球基因疗法核准的增长得益于监管机构日益增长的认可、持续的科学进步以及对以往难以治疗的遗传疾病创新治疗方法的需求不断增加。基因疗法上市试验是监管机构为确保产品品质和病人安全而製定的必要程序，旨在批次放行前评估其效力、纯度、鑑别和安全性。例如，根据美国政府研究机构国家生物技术资讯中心（NCBI）的数据，截至2023年11月，全球已有超过100种基因疗法、细胞疗法和核糖核酸（RNA）疗法获得核准，另有超过3700种治疗方法处于临床和临床前开发阶段。因此，全球基因疗法核准数量的不断增长预计将推动基因疗法上市试验市场的发展。

基因治疗产品放行检测市场的主要企业正致力于开发创新解决方案，例如基于数位PCR的分析检测平台，以满足日益增长的对高精度、高灵敏度和标准化检测方法的需求，从而确保复杂基因治疗产品的安全性、有效性和合规性。基于数位聚合酵素链锁反应（PCR）的分析检测平台是一种先进的分子系统，它透过将样本分成数千个独立的反应，精确量化去氧核糖核酸（DNA）或核糖核酸（RNA），从而实现对核酸标靶的超灵敏和绝对测量。例如，2025年4月，总部位于德国的分子诊断和生命科学工具供应商凯杰公司（QIAGEN NV）扩展了其QIAcuity数位PCR产品组合，新增了旨在增强细胞和基因治疗生产品管的慢病毒解决方案。这些新增产品支援病毒载体的基因组滴度测定、载体拷贝数测量以及具有复製能力的慢病毒检测，从而为製程开发、批次放行和合规性检测提供高精度分析。该平台提供专门设计的试剂盒，用于单重和多重应用中的绝对定量、高重复性和关键基因治疗载体，与许多传统检测方法相比，可提供更可靠、更可重复的结果。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球基因治疗产品上市检测市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 活性成分的高灵敏度定量分析
    • 快速无菌检测平台
    • 自动化批次放行分析
    • 多项品管面板
    • 高级向量识别测试

第五章 终端用户产业市场分析

  • 製药公司
  • 生技公司
  • 合约研究机构
  • 学术研究机构
  • 基因治疗开发公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球基因疗法产品放行检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球基因治疗药物释放检测市场规模、对比及成长率分析
  • 全球基因治疗产品上市检测市场表现：规模与成长，2020-2025年
  • 全球基因治疗产品放行检测市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 测试类型
  • 效能试验、纯度试验、鑑别试验、安全性试验、无菌试验及其他试验类型
  • 依产品类型
  • 检测试剂盒、试剂、仪器及服务
  • 透过治疗方法
  • 体内基因治疗，体外基因治疗
  • 透过使用
  • 临床诊断、研究、品管、製程开发及其他应用
  • 最终用户
  • 製药和生物技术公司、学术和研究机构、受託研究机构以及其他最终用户
  • 按类型细分：疗效试验
  • 功能活性测定、基因表现量测量、生物活性评估、剂量反应评估。
  • 按类型细分：纯度测试
  • 残留宿主细胞蛋白分析、残留去氧核糖核酸定量、製程相关杂质检测、产品相关杂质评估。
  • 按类型细分：身分识别测试
  • 基因序列验证、载体身份验证、转基因身份分析、细胞株真实性验证。
  • 按类型细分：安全测试
  • 外来性因素检测、病毒复製能力检测、内毒素浓度评估、毒性评估。
  • 按类型细分：无菌检测
  • 细菌污染检测、真菌污染检测、霉浆菌检测和环境监测的验证。
  • 按类型细分：其他测试类型
  • 稳定性测试、包装完整性测试、保质期测定和运输/储存条件测试。

第十章 区域与国别分析

  • 全球基因治疗产品放行检测市场：依地区划分，实际结果及预测，2020-2025年、2025-2030年、2035年
  • 全球基因疗法产品放行检测市场：依国家划分，实际结果及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 基因疗法产品上市检测市场：竞争格局及市场占有率（2024年）
  • 基因治疗产品上市检测市场：公司评估矩阵
  • 基因治疗药物释放检测市场：公司概况
    • Thermo Fisher Scientific Inc.
    • Boehringer Ingelheim BioXcellence GmbH
    • Fujifilm Diosynth Biotechnologies Inc.
    • AGC Biologics Inc.
    • SGS SA

第37章 其他大型企业和创新企业

  • Lonza Group AG, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Sartorius AG, Samsung Biologics Co. Ltd., Bio-Rad Laboratories Inc., Pace Analytical Services LLC, KBI Biopharma Inc., BioAgilytix Labs LLC, Viralgen Vector SL, GenScript ProBio LLC, KCAS Bioanalytical Services, Creative Biolabs LLC, Cellipont Bioservices Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章：预计进入市场的Start-Ups

第四十章 重大併购

第41章 具有高市场潜力的国家、细分市场与策略

  • 2030年基因疗法释放检测市场：提供新机会的国家
  • 2030年基因疗法产品上市检测市场：新兴细分市场机会
  • 2030年基因疗法释放检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第42章附录

简介目录
Product Code: PS5MRTGT01_G26Q1

Release testing for gene therapy is a quality assurance procedure performed to verify that gene therapy products meet established safety, effectiveness, purity, and identity requirements before patient use. It ensures that gene therapy treatments are safe, reliable, and compliant with regulatory standards for clinical and commercial application.

The primary types of release testing for gene therapy include potency testing, purity testing, identity testing, safety testing, sterility testing, and other test types. Potency testing refers to procedures used to evaluate the biological activity of gene therapy products to ensure effectiveness and consistency. These tests are conducted for product types including assay kits, reagents, instruments, and services. They are used for therapy types such as in vivo gene therapy and ex vivo gene therapy. They are applied across applications including clinical diagnostics, research, quality control, process development, and other applications, and are utilized by end users including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and other end users.

Tariffs are impacting the release testing for gene therapy market by increasing the cost of imported assay kits, analytical instruments, and specialized reagents. Higher duties are raising operational costs across potency, purity, and safety testing segments. Contract research organizations and biotech manufacturers that depend on imported testing systems are most affected. Regions relying on global laboratory equipment supply chains, especially in asia pacific and europe, are experiencing procurement delays. Testing providers are moving toward regional suppliers and localized sourcing strategies. Tariffs are also encouraging domestic production of test kits and analytical tools. This supports local laboratory supply ecosystems and strengthens long term testing capacity.

The release testing for gene therapy market research report is one of a series of new reports from The Business Research Company that provides release testing for gene therapy market statistics, including release testing for gene therapy industry global market size, regional shares, competitors with a release testing for gene therapy market share, detailed release testing for gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the release testing for gene therapy industry. This release testing for gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The release testing for gene therapy market size has grown rapidly in recent years. It will grow from $1.43 billion in 2025 to $1.67 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to rise in gene therapy trials, strict regulatory quality standards, growth in viral vector production, expansion of biologics testing labs, increase in advanced therapy approvals.

The release testing for gene therapy market size is expected to see rapid growth in the next few years. It will grow to $3.08 billion in 2030 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to growth in commercial gene therapies, rising demand for rapid release testing, expansion of contract testing services, increasing regulatory scrutiny, adoption of automated qc platforms. Major trends in the forecast period include high sensitivity potency assays, rapid sterility testing platforms, automated batch release analytics, multi parameter quality control panels, advanced vector identity testing.

The rising number of global approvals for gene therapies is expected to fuel the growth of the release testing for gene therapy market going forward. Gene therapies are medical treatments that involve the introduction, removal, or modification of genetic material within a patient's cells to treat or prevent disease. Growth in global gene therapy approvals is supported by increasing regulatory acceptance, ongoing scientific advancements, and rising demand for innovative treatments targeting previously untreatable genetic disorders. Release testing for gene therapy is a regulatory requirement that ensures product quality and patient safety through evaluations of potency, purity, identity, and safety prior to batch release. For instance, in November 2023, according to the National Center for Biotechnology Information, a U.S.-based governmental research resource, more than 100 gene, cell, and ribonucleic acid (RNA) therapies had been approved globally as of early 2023, with over 3,700 additional therapies in clinical and preclinical development. Therefore, the increasing number of global gene therapy approvals is expected to support the growth of the release testing for gene therapy market.

Leading companies operating in the release testing for gene therapy market are focusing on developing innovative solutions, such as digital PCR-based analytical testing platforms, to address the growing need for highly accurate, sensitive, and standardized methods that ensure product safety, potency, and regulatory compliance for complex gene therapy products. Digital polymerase chain reaction (PCR)-based analytical testing platforms are advanced molecular systems that precisely quantify deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) by partitioning samples into thousands of individual reactions, enabling highly sensitive and absolute measurement of nucleic acid targets. For example, in April 2025, QIAGEN N.V., a Germany-based provider of molecular diagnostics and life science tools, expanded its QIAcuity digital PCR portfolio with new lentivirus solutions designed to enhance quality control in cell and gene therapy manufacturing. These additions support viral vector genome titration, vector copy number determination, and replication-competent lentivirus detection, enabling high-precision analytics for process development, batch release, and regulatory compliance. The platform offers absolute quantification across singleplex and multiplex applications, strong repeatability, and tailored kits for critical gene therapy vectors, providing more reliable and reproducible results than many conventional testing approaches.

In January 2026, bioMerieux S.A., a France-based biotechnology company, acquired Accellix Inc. for approximately $41 million (€35 million). With this acquisition, bioMerieux aimed to strengthen and expand its pharmaceutical quality control portfolio particularly in rapid, automated flow cytometry solutions for cell and gene therapy manufacturing to support the growing advanced therapies market and improve testing capabilities across the therapy development lifecycle. Accellix Inc. is a US-based quality control technology provider that enables rapid, automated flow cytometry-based release testing for cell and gene therapies, specifically supporting critical release parameters such as cell purity and viability.

Major companies operating in the release testing for gene therapy market are Thermo Fisher Scientific Inc., Boehringer Ingelheim BioXcellence GmbH, Fujifilm Diosynth Biotechnologies Inc., AGC Biologics Inc., SGS SA, Lonza Group AG, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Sartorius AG, Samsung Biologics Co. Ltd., Bio-Rad Laboratories Inc., Pace Analytical Services LLC, KBI Biopharma Inc., BioAgilytix Labs LLC, Viralgen Vector S.L., GenScript ProBio LLC, KCAS Bioanalytical Services, Creative Biolabs LLC, Cellipont Bioservices Inc.

North America was the largest region in the release testing for gene therapy in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the release testing for gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the release testing for gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The release testing for gene therapy market includes revenues earned by entities through the quality control and analytical testing services, stability assessment, method validation, regulatory compliance testing, and batch release support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Release Testing For Gene Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses release testing for gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for release testing for gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The release testing for gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Potency Testing; Purity Testing; Identity Testing; Safety Testing; Sterility Testing; Other Test Types
  • 2) By Product Type: Assay Kits; Reagents; Instruments; Services
  • 3) By Therapy Type: In Vivo Gene Therapy; Ex Vivo Gene Therapy
  • 4) By Application: Clinical Diagnostics; Research; Quality Control; Process Development; Other Applications
  • 5) By End-User: Pharmaceutical and Biotechnology Companies; Academic and Research Institutes; Contract Research Organizations; Other End-Users
  • Subsegments:
  • 1) By Potency Testing: Functional Activity Assays; Gene Expression Level Measurement; Biological Activity Evaluation; Dose Response Assessment
  • 2) By Purity Testing: Residual Host Cell Protein Analysis; Residual Deoxyribonucleic Acid Quantification; Process Related Impurity Testing; Product Related Impurity Assessment
  • 3) By Identity Testing: Genetic Sequence Confirmation; Vector Identity Verification; Transgene Identity Analysis; Cell Line Authentication
  • 4) By Safety Testing: Adventitious Agent Testing; Replication Competent Virus Detection; Endotoxin Level Evaluation; Toxicity Assessment
  • 5) By Sterility Testing: Bacterial Contamination Testing; Fungal Contamination Testing; Mycoplasma Detection; Environmental Monitoring Validation
  • 6) By Other Test Types: Stability Testing; Packaging Integrity Testing; Shelf Life Determination; Transport and Storage Condition Testing
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Boehringer Ingelheim BioXcellence GmbH; Fujifilm Diosynth Biotechnologies Inc.; AGC Biologics Inc.; SGS SA; Lonza Group AG; Eurofins Scientific SE; WuXi AppTec Co. Ltd.; Charles River Laboratories International Inc.; Sartorius AG; Samsung Biologics Co. Ltd.; Bio-Rad Laboratories Inc.; Pace Analytical Services LLC; KBI Biopharma Inc.; BioAgilytix Labs LLC; Viralgen Vector S.L.; GenScript ProBio LLC; KCAS Bioanalytical Services; Creative Biolabs LLC; Cellipont Bioservices Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Release Testing For Gene Therapy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Release Testing For Gene Therapy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Release Testing For Gene Therapy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Release Testing For Gene Therapy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 High Sensitivity Potency Assays
    • 4.2.2 Rapid Sterility Testing Platforms
    • 4.2.3 Automated Batch Release Analytics
    • 4.2.4 Multi Parameter Quality Control Panels
    • 4.2.5 Advanced Vector Identity Testing

5. Release Testing For Gene Therapy Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Biotechnology Companies
  • 5.3 Contract Research Organizations
  • 5.4 Academic Research Institutes
  • 5.5 Gene Therapy Developers

6. Release Testing For Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Release Testing For Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Release Testing For Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Release Testing For Gene Therapy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Release Testing For Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Release Testing For Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Release Testing For Gene Therapy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Release Testing For Gene Therapy Market Segmentation

  • 9.1. Global Release Testing For Gene Therapy Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Potency Testing, Purity Testing, Identity Testing, Safety Testing, Sterility Testing, Other Test Types
  • 9.2. Global Release Testing For Gene Therapy Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Assay Kits, Reagents, Instruments, Services
  • 9.3. Global Release Testing For Gene Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Vivo Gene Therapy, Ex Vivo Gene Therapy
  • 9.4. Global Release Testing For Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Diagnostics, Research, Quality Control, Process Development, Other Applications
  • 9.5. Global Release Testing For Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations, Other End-Users
  • 9.6. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Potency Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Functional Activity Assays, Gene Expression Level Measurement, Biological Activity Evaluation, Dose Response Assessment
  • 9.7. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Purity Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Residual Host Cell Protein Analysis, Residual Deoxyribonucleic Acid Quantification, Process Related Impurity Testing, Product Related Impurity Assessment
  • 9.8. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Identity Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genetic Sequence Confirmation, Vector Identity Verification, Transgene Identity Analysis, Cell Line Authentication
  • 9.9. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Safety Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adventitious Agent Testing, Replication Competent Virus Detection, Endotoxin Level Evaluation, Toxicity Assessment
  • 9.10. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Sterility Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bacterial Contamination Testing, Fungal Contamination Testing, Mycoplasma Detection, Environmental Monitoring Validation
  • 9.11. Global Release Testing For Gene Therapy Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stability Testing, Packaging Integrity Testing, Shelf Life Determination, Transport and Storage Condition Testing

10. Release Testing For Gene Therapy Market Regional And Country Analysis

  • 10.1. Global Release Testing For Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Release Testing For Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Release Testing For Gene Therapy Market

  • 11.1. Asia-Pacific Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Release Testing For Gene Therapy Market

  • 12.1. China Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Release Testing For Gene Therapy Market

  • 13.1. India Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Release Testing For Gene Therapy Market

  • 14.1. Japan Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Release Testing For Gene Therapy Market

  • 15.1. Australia Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Release Testing For Gene Therapy Market

  • 16.1. Indonesia Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Release Testing For Gene Therapy Market

  • 17.1. South Korea Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Release Testing For Gene Therapy Market

  • 18.1. Taiwan Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Release Testing For Gene Therapy Market

  • 19.1. South East Asia Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Release Testing For Gene Therapy Market

  • 20.1. Western Europe Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Release Testing For Gene Therapy Market

  • 21.1. UK Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Release Testing For Gene Therapy Market

  • 22.1. Germany Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Release Testing For Gene Therapy Market

  • 23.1. France Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Release Testing For Gene Therapy Market

  • 24.1. Italy Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Release Testing For Gene Therapy Market

  • 25.1. Spain Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Release Testing For Gene Therapy Market

  • 26.1. Eastern Europe Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Release Testing For Gene Therapy Market

  • 27.1. Russia Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Release Testing For Gene Therapy Market

  • 28.1. North America Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Release Testing For Gene Therapy Market

  • 29.1. USA Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Release Testing For Gene Therapy Market

  • 30.1. Canada Release Testing For Gene Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Release Testing For Gene Therapy Market

  • 31.1. South America Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Release Testing For Gene Therapy Market

  • 32.1. Brazil Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Release Testing For Gene Therapy Market

  • 33.1. Middle East Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Release Testing For Gene Therapy Market

  • 34.1. Africa Release Testing For Gene Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Release Testing For Gene Therapy Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Release Testing For Gene Therapy Market Regulatory and Investment Landscape

36. Release Testing For Gene Therapy Market Competitive Landscape And Company Profiles

  • 36.1. Release Testing For Gene Therapy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Release Testing For Gene Therapy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Release Testing For Gene Therapy Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Boehringer Ingelheim BioXcellence GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Fujifilm Diosynth Biotechnologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. AGC Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

37. Release Testing For Gene Therapy Market Other Major And Innovative Companies

  • Lonza Group AG, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Sartorius AG, Samsung Biologics Co. Ltd., Bio-Rad Laboratories Inc., Pace Analytical Services LLC, KBI Biopharma Inc., BioAgilytix Labs LLC, Viralgen Vector S.L., GenScript ProBio LLC, KCAS Bioanalytical Services, Creative Biolabs LLC, Cellipont Bioservices Inc.

38. Global Release Testing For Gene Therapy Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Release Testing For Gene Therapy Market

41. Release Testing For Gene Therapy Market High Potential Countries, Segments and Strategies

  • 41.1 Release Testing For Gene Therapy Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Release Testing For Gene Therapy Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Release Testing For Gene Therapy Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer